Adult onset type 1 diabetes can be mistaken for type 2 because it often develops gradually and may not require insulin at diagnosis. Latent autoimmune diabetes in adults (LADA) is a term for this slower-progressing form of autoimmune diabetes. No single symptom or test settles the diagnosis: clinicians weigh how diabetes is progressing, islet autoantibody results and C-peptide, a measure of the body’s own insulin production.
What LADA Means
Type 1 diabetes is caused by the immune system attacking the insulin-producing beta cells in the pancreas. In adults, that process may be slower than in the familiar rapid-onset pattern, so blood sugar can rise gradually and early treatment may resemble treatment for type 2 diabetes. LADA is commonly used for adults with autoimmune diabetes who do not need insulin for at least six months after diagnosis. That definition is debated, however, and there is no universally accepted LADA treatment algorithm. Some clinicians use the broader term adult-onset type 1 diabetes instead.
Diabetes symptoms such as increased thirst and urination, fatigue or unintentional weight loss do not reliably distinguish LADA from type 2. Features that may lead a clinician to investigate autoimmune diabetes include unexpectedly rapid worsening of blood sugar, limited response to type 2 diabetes medicines, weight loss, a lower body weight, or a personal or family history of autoimmune disease. These are clues, not proof: type 2 can occur in people who are not overweight, and people with autoimmune diabetes can have higher body weight.
How Adult Onset Type 1 Diabetes Is Investigated
Islet autoantibodies are proteins that can indicate an immune attack on pancreatic cells. Tests may include GAD antibodies (GADA), the most common antibody in LADA, as well as IA-2, ZnT8, islet-cell or insulin autoantibodies. A positive result in someone whose clinical course already suggests type 1 diabetes usually supports an autoimmune cause. But a single positive antibody in someone whose presentation strongly suggests type 2 may be less conclusive, because type 2 is much more common among adults with newly diagnosed diabetes. Antibody tests can also miss cases; a negative result does not always rule out autoimmune diabetes.
C-peptide is released when the pancreas makes insulin. A C-peptide blood test therefore helps show how much insulin your body is still producing, including if you use injected insulin. Low levels can support insulin deficiency, while higher levels suggest more insulin production. But C-peptide is not a stand-alone type-of-diabetes test. Levels can overlap between diabetes types, and insulin production may still be measurable early in autoimmune diabetes. Results are best interpreted alongside blood glucose, the clinical course and antibody tests. Assays are not fully standardized across laboratories, so a value should be considered with its lab reference range rather than treated as a universal cutoff.
Why Treatment May Change
Some people with LADA initially manage blood glucose with lifestyle changes or non-insulin medicines. As autoimmune damage reduces beta-cell function, those treatments may become less effective and insulin may be needed. The pace varies: antibody patterns and the rate of C-peptide decline differ from person to person, so the label alone cannot predict when insulin will be required.
If you have diabetes and your glucose control is worsening faster than expected, discuss the pattern with your clinician. They can decide whether antibody testing, C-peptide measurement or specialist input would clarify the diagnosis and guide treatment. The important issue is not the name by itself, but recognizing when your body is making too little insulin and adjusting care accordingly.
When To Get Urgent Help
Severe insulin deficiency can lead to diabetic ketoacidosis (DKA), a medical emergency. Seek emergency care for symptoms such as vomiting, abdominal pain, deep or rapid breathing, fruity-smelling breath, marked drowsiness or confusion—especially when they occur with high blood glucose or ketones. Do not wait for routine antibody or C-peptide test results if DKA is possible. If you are concerned about new or worsening diabetes symptoms, contact a healthcare professional promptly; this article cannot diagnose your diabetes type or determine your treatment.
